Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Evolutionary Relationships through Genome Comparisons

Evolutionary Relationships through Genome Comparisons

Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cross-Device Adaptation of Mirai for Mammography-Based Breast Cancer Risk Prediction.

medRxiv : the preprint server for health sciences·2026

Same author

Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival.

European journal of human genetics : EJHG·2026

Same author

Inherited genetic risk factors in young-onset lung cancer.

medRxiv : the preprint server for health sciences·2026

Same author

Cell-type aware transcriptome-wide association study of mammographic density phenotypes.

medRxiv : the preprint server for health sciences·2025

Same author

The flow and flux of feeling: relations between attention to emotion and emotion reactivity dynamics.

Cognition & emotion·2025

Same author

Distinct characteristics of lymphoid and myeloid clonal hematopoiesis in World Trade Center first responders.

medRxiv : the preprint server for health sciences·2025

Search research articles

Related Experiment Video

Updated: Jul 12, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Power analysis for genome-wide association studies.

Robert J Klein¹

¹Program in Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA. kleinr@mskcc.org

|August 30, 2007

Summary

Designing genome-wide association studies (GWAS) requires careful power calculations. Optimizing sample size and genotyping strategy is crucial for effectively deciphering complex disease genetics.

Area of Science:

Genetics
Genomics
Population Genetics

Background:

Genome-wide association studies (GWAS) are emerging as a powerful method for understanding the genetic basis of complex diseases.
Accurate power calculations are essential for selecting appropriate sample sizes and genotyping platforms in GWAS.
These calculations must consider genetic models, tag single nucleotide polymorphism (SNP) selection, and the specific population under study.

Purpose of the Study:

To outline the critical factors influencing the design of genome-wide association studies.
To emphasize the importance of power calculations in optimizing GWAS parameters.
To provide guidance on selecting appropriate sample sizes and genotyping strategies.

Main Methods:

Power calculations for GWAS were assessed using tag SNPs and extensive genotyped SNPs.

More Related Videos

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

Related Experiment Videos

Last Updated: Jul 12, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

Infinium Assay for Large-scale SNP Genotyping Applications

Infinium Assay for Large-scale SNP Genotyping Applications

Published on: November 19, 2013

The HapMap project's population data was utilized as a representative resource.

The relationship between sample size, effect size, and power was evaluated.

Main Results:

GWAS power is computable using tag SNPs and large SNP datasets from representative populations like HapMap.
Study power increases with larger sample sizes and greater effect sizes.
The selection of tag SNPs significantly impacts study power, with potential benefits from genotyping more individuals at fewer SNPs.

Conclusions:

Thoughtful design is paramount for successful genome-wide association studies.
The selection of genotyping platforms and sample sizes should be informed by rigorous power calculations.
Optimizing these parameters enhances the ability to identify genetic factors underlying complex diseases.